Oncotelic Therapeutics Inc.

Oncotelic Therapeutics Inc.https://investorshangout.com/Oncotelic-Therapeutics-Inc-OTLC-93629/en-usMon, 19 Oct 2026 23:11:16 GMTCopyright InvestorsHangout.comNetworkNewsWire: Oncotelic Highlights PDAOAI Discovery Platform and HCC Research at Drug Discovery 2026 -https://investorshangout.com/post/view?id=6848563https://investorshangout.com/post/view?id=6848563Thu, 15 Oct 2026 20:17:42 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Opens BIO REBOOT Registration, Annhttps://investorshangout.com/post/view?id=6847297https://investorshangout.com/post/view?id=6847297Mon, 05 Oct 2026 19:59:02 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Present at OTCQB Virtual Investhttps://investorshangout.com/post/view?id=6839561https://investorshangout.com/post/view?id=6839561Mon, 03 Aug 2026 20:47:40 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Publishes Preclinical Data Supporthttps://investorshangout.com/post/view?id=6838307https://investorshangout.com/post/view?id=6838307Wed, 22 Jul 2026 20:01:37 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Brings AI and Robotics Together in New Plahttps://investorshangout.com/post/view?id=6837631https://investorshangout.com/post/view?id=6837631Wed, 15 Jul 2026 20:43:20 GMTNetworkNewsWire: Oncotelic Therapeutics Inc. (OTLC) Targets Biotech’s Manufacturing Bottleneck with AI-Powered GMPhttps://investorshangout.com/post/view?id=6837018https://investorshangout.com/post/view?id=6837018Thu, 09 Jul 2026 21:43:44 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports Positive Safety Review forhttps://investorshangout.com/post/view?id=6836733https://investorshangout.com/post/view?id=6836733Tue, 07 Jul 2026 21:18:15 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Publishes Peer-Reviewed Validation ofhttps://investorshangout.com/post/view?id=6835806https://investorshangout.com/post/view?id=6835806Mon, 29 Jun 2026 20:44:20 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Eyes Opportunity Through AI and Pharmaceuthttps://investorshangout.com/post/view?id=6835183https://investorshangout.com/post/view?id=6835183Wed, 24 Jun 2026 19:57:24 GMTNetworkNewsWire: The $410 Billion Drug Delivery Revolution: Why Drug Delivery May Be the Next Major Frontier in Onhttps://investorshangout.com/post/view?id=6835046https://investorshangout.com/post/view?id=6835046Tue, 23 Jun 2026 22:16:53 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Launches AI-Powered GMP Manufacturhttps://investorshangout.com/post/view?id=6834532https://investorshangout.com/post/view?id=6834532Thu, 18 Jun 2026 21:25:21 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances AI-Powered GMP Manufacturhttps://investorshangout.com/post/view?id=6834350https://investorshangout.com/post/view?id=6834350Wed, 17 Jun 2026 21:09:10 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) to Showcase AI Drug Discovery Plathttps://investorshangout.com/post/view?id=6833017https://investorshangout.com/post/view?id=6833017Mon, 08 Jun 2026 21:17:03 GMTNetworkNewsWire: Oncotelic Therapeutics Inc. (OTLC) Combines Nanomedicine, AI, and Robotics to Advance Precision Ohttps://investorshangout.com/post/view?id=6832784https://investorshangout.com/post/view?id=6832784Fri, 05 Jun 2026 21:55:06 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsAudio Editohttps://investorshangout.com/post/view?id=6832783https://investorshangout.com/post/view?id=6832783Fri, 05 Jun 2026 21:41:58 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial ohttps://investorshangout.com/post/view?id=6832625https://investorshangout.com/post/view?id=6832625Thu, 04 Jun 2026 20:14:53 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial ohttps://investorshangout.com/post/view?id=6832478https://investorshangout.com/post/view?id=6832478Wed, 03 Jun 2026 20:44:38 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Expands Sapu003 Phase 1b Program, https://investorshangout.com/post/view?id=6832474https://investorshangout.com/post/view?id=6832474Wed, 03 Jun 2026 20:38:41 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial ohttps://investorshangout.com/post/view?id=6832309https://investorshangout.com/post/view?id=6832309Wed, 03 Jun 2026 00:06:15 GMTNetworkNewsWire: Oncotelic Therapeutics Inc. (OTLC) Holds $388M JV Valuation as Pipeline Momentum Builds https://investorshangout.com/post/view?id=6832121https://investorshangout.com/post/view?id=6832121Mon, 01 Jun 2026 21:46:43 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances Delivery-Focused Oncologyhttps://investorshangout.com/post/view?id=6832114https://investorshangout.com/post/view?id=6832114Mon, 01 Jun 2026 21:25:15 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Nano to Present Decipartihttps://investorshangout.com/post/view?id=6831610https://investorshangout.com/post/view?id=6831610Thu, 28 May 2026 23:03:02 GMTNetworkNewsWire: Oncotelic Therapeutics Inc. (OTLC) Advances CNS Drug Delivery Strategy as BBB Breakthroughs Drivehttps://investorshangout.com/post/view?id=6831200https://investorshangout.com/post/view?id=6831200Tue, 26 May 2026 21:39:57 GMTNetworkNewsWire: Oncotelic Therapeutics Inc. (OTLC) Proving Small Biotech Can Out-Innovate Big Pharma with 28 Millhttps://investorshangout.com/post/view?id=6830660https://investorshangout.com/post/view?id=6830660Thu, 21 May 2026 21:23:21 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics Inc. (OTLC) Expands Beyond Biotech with AI-Enhanced Rohttps://investorshangout.com/post/view?id=6830324https://investorshangout.com/post/view?id=6830324Tue, 19 May 2026 21:36:03 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports First-Quarter Results, Highttps://investorshangout.com/post/view?id=6829837https://investorshangout.com/post/view?id=6829837Fri, 15 May 2026 21:13:32 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsAudio Editohttps://investorshangout.com/post/view?id=6829834https://investorshangout.com/post/view?id=6829834Fri, 15 May 2026 21:05:56 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial ohttps://investorshangout.com/post/view?id=6829644https://investorshangout.com/post/view?id=6829644Thu, 14 May 2026 20:37:16 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial ohttps://investorshangout.com/post/view?id=6829406https://investorshangout.com/post/view?id=6829406Wed, 13 May 2026 21:25:47 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Announces First Patient Dosed in Phttps://investorshangout.com/post/view?id=6829405https://investorshangout.com/post/view?id=6829405Wed, 13 May 2026 21:22:12 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial ohttps://investorshangout.com/post/view?id=6829192https://investorshangout.com/post/view?id=6829192Tue, 12 May 2026 20:51:34 GMTNetworkNewsWire: The Partnership Playbook: Oncotelic Therapeutics Inc. (OTLC) Advancing Its Pipeline Without Diluthttps://investorshangout.com/post/view?id=6828953https://investorshangout.com/post/view?id=6828953Mon, 11 May 2026 20:45:40 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Targets CNS Drug Delivery Opportunhttps://investorshangout.com/post/view?id=6828950https://investorshangout.com/post/view?id=6828950Mon, 11 May 2026 20:31:28 GMTNetworkNewsWire: Pipeline Maturity is Redefining Valuations in Biotech - The biotechnology industry is gohttps://investorshangout.com/post/view?id=6828456https://investorshangout.com/post/view?id=6828456Thu, 07 May 2026 19:59:10 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Completes $12.5M N2B Asset Transfehttps://investorshangout.com/post/view?id=6828298https://investorshangout.com/post/view?id=6828298Wed, 06 May 2026 20:40:34 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Advances AI and Robotics Platform https://investorshangout.com/post/view?id=6827426https://investorshangout.com/post/view?id=6827426Thu, 30 Apr 2026 20:57:41 GMTNetworkNewsWire: The Evidence-Interrogation Play: How Oncotelic Therapeutics Inc.’s (OTLC) PDAOAI Platform Fits Phhttps://investorshangout.com/post/view?id=6827058https://investorshangout.com/post/view?id=6827058Tue, 28 Apr 2026 21:12:29 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Highlights Partnership Strategy tohttps://investorshangout.com/post/view?id=6826418https://investorshangout.com/post/view?id=6826418Fri, 24 Apr 2026 21:07:18 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in NetworkNewsAudio Editohttps://investorshangout.com/post/view?id=6826417https://investorshangout.com/post/view?id=6826417Fri, 24 Apr 2026 21:05:23 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In BioMedWire Editorial Ohttps://investorshangout.com/post/view?id=6826215https://investorshangout.com/post/view?id=6826215Thu, 23 Apr 2026 21:01:13 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial ohttps://investorshangout.com/post/view?id=6825697https://investorshangout.com/post/view?id=6825697Tue, 21 Apr 2026 20:36:54 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial Hhttps://investorshangout.com/post/view?id=6825431https://investorshangout.com/post/view?id=6825431Mon, 20 Apr 2026 20:54:06 GMTNetworkNewsWire: Oncotelic Therapeutics Inc. (OTLC) Expands Beyond Biotech Through AI-Robotics Pivot, Unlocking Nehttps://investorshangout.com/post/view?id=6824696https://investorshangout.com/post/view?id=6824696Thu, 16 Apr 2026 21:19:00 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Reports FY 2025 Net Income of $249https://investorshangout.com/post/view?id=6824691https://investorshangout.com/post/view?id=6824691Thu, 16 Apr 2026 21:08:00 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In AINewsWire Editorial Ohttps://investorshangout.com/post/view?id=6823792https://investorshangout.com/post/view?id=6823792Fri, 10 Apr 2026 21:04:12 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured In Editorial On AI-Driven Trhttps://investorshangout.com/post/view?id=6823654https://investorshangout.com/post/view?id=6823654Thu, 09 Apr 2026 20:55:31 GMTNetworkNewsWire: From Big Data to Better Drugs: How AI-Driven Platforms Are Changing Cancer Research - Cahttps://investorshangout.com/post/view?id=6823490https://investorshangout.com/post/view?id=6823490Wed, 08 Apr 2026 20:27:38 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in AINewsWire Editorial ohttps://investorshangout.com/post/view?id=6823486https://investorshangout.com/post/view?id=6823486Wed, 08 Apr 2026 20:12:51 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Partners with TechForce Robotics thttps://investorshangout.com/post/view?id=6822779https://investorshangout.com/post/view?id=6822779Thu, 02 Apr 2026 21:18:38 GMTNetworkNewsWire: NetworkNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) To Present Deciparticle Platform Ahttps://investorshangout.com/post/view?id=6821380https://investorshangout.com/post/view?id=6821380Tue, 24 Mar 2026 21:12:16 GMT